This HTML5 document contains 106 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1038/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q56964283
rdf:type
wikibase:Item
schema:description
artículu científicu наукова стаття, опублікована в грудні 2012 wetenschappelijk artikel article im Dezember 2012 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q56964283-55C44704-A7AB-4C94-8831-039B0516BF67
wdt:P577
2012-08-29T00:00:00Z
p:P407
wds:Q56964283-A5CF48EE-703F-4768-BDDF-DC8D043020D5
wdt:P407
wd:Q1860
p:P2888
wds:Q56964283-42D10636-55F8-4927-A464-0A72B40DB31F
wdt:P2888
n11:ki.2012.275
p:P2860
wds:Q56964283-F7CF5AE3-CC21-452E-AEFB-23315D576BC8 wds:Q56964283-A7B0A3BA-B94E-48D8-9F0E-F3C1EB185FED wds:Q56964283-B169DA92-78E2-4C95-86A6-FD7836568832 wds:Q56964283-B9787551-398E-4304-851D-77FB4BD2CD17 wds:Q56964283-C3E00EE0-E4C1-43AE-8AFD-DA3B2A9A6D68 wds:Q56964283-E04884D9-949C-4106-AF9E-4CCBC154C0CA wds:Q56964283-E1D51BBE-65A7-492F-AEC0-E02A6598E00F wds:Q56964283-F79A918F-BA83-49AE-8594-57D49D0A0667 wds:Q56964283-3F1D783A-80FC-480D-A4EF-623C5EF8D12A wds:Q56964283-47050EFD-43EA-49AE-856F-21E92C31D316 wds:Q56964283-5FB49376-F5EA-4419-9927-25D438165D59 wds:Q56964283-67A13F17-998F-4DFC-8426-5F1125D8BB26 wds:Q56964283-783E91DF-E62D-4F2D-80F6-E7A24BBEC829 wds:Q56964283-7C50FDCE-023C-4018-A360-1848B4EABD64 wds:Q56964283-8D4B908C-3EC1-4177-8D91-55086881B0C3 wds:Q56964283-970E0A49-00AC-45D9-B322-562DD162D334 wds:Q56964283-02DE485C-BAD1-47EE-AC95-938CA163913D wds:Q56964283-12F596CE-3BF4-4118-9091-F959373669FA wds:Q56964283-20216630-506C-4DC9-B060-8FC2641C51F4 wds:Q56964283-26BAD6EB-C5BC-456F-BDEC-668D745DD60C wds:Q56964283-29C41056-FD7C-4D13-AC70-4F5C34222218 wds:Q56964283-323C0C2A-8BF8-4307-8C51-3083A569D962 wds:Q56964283-3711771D-6DA2-4273-8569-762F548E2E04 wds:Q56964283-376C5169-09EE-4318-8129-2D03C364BE19 wds:Q56964283-3AC4AE5B-53B6-4C47-B0F6-6065D54A9971
wdt:P2860
wd:Q33684208 wd:Q34569129 wd:Q30443007 wd:Q57250970 wd:Q48339027 wd:Q37770464 wd:Q33973244 wd:Q84387223 wd:Q34709098 wd:Q83186748 wd:Q72377634 wd:Q44231315 wd:Q34581679 wd:Q44190768 wd:Q37796485 wd:Q34547726 wd:Q55052760 wd:Q37694117 wd:Q22306116 wd:Q44261207 wd:Q46907487 wd:Q36138277 wd:Q34551988 wd:Q37947486 wd:Q40376981
p:P2093
wds:Q56964283-B50B1F50-66A2-4FF3-8246-874E124D2695 wds:Q56964283-0E454CF3-2F26-458A-B7EE-100A12F25EE4 wds:Q56964283-3A6ACF01-B252-4843-A490-ED965980AF12 wds:Q56964283-2D7E0E7B-015B-4385-B273-5E2E45DF0B26 wds:Q56964283-8487B7BB-D209-4057-BB5F-849835958F98 wds:Q56964283-B30BED8E-E325-425A-A875-E356872F916A wds:Q56964283-A98FC29B-314A-47C6-833D-0DD4FB3A240B
wdt:P2093
Richard C Josiassen William T Abraham Johannes Hensen Cesare Orlandi LIBRA Study Group DeoDatta S Chafekar Peter A Gross
rdfs:label
Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia
skos:prefLabel
Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia
schema:name
Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia
p:P50
wds:Q56964283-489C1863-3C27-4F15-A21F-3CBB4B9967C6
wdt:P50
wd:Q67522454
p:P1476
wds:Q56964283-7CBF803B-FB69-4BC4-A0ED-0FC5DF6B213F
wdt:P1476
Lixivaptan safely and effectively corrects serum sodium concentrations in hospitalized patients with euvolemic hyponatremia
p:P304
wds:Q56964283-A9655E16-1115-4DE7-852B-0E94CF888B99
wdt:P304
1223-1230
p:P31
wds:Q56964283-0A2E01FA-FD51-4F94-B61B-C362663AD2BC
wdt:P31
wd:Q13442814
p:P921
wds:Q56964283-F5485723-C87C-4CE2-9E72-D28E2A714577 wds:Q56964283-AC9783C3-8661-4BAC-ACF1-1613BFEE43AE
wdt:P921
wd:Q824292 wd:Q3140971
p:P698
wds:Q56964283-AC99D773-6C2E-4A60-8737-787365D2C9C1
wdtn:P698
n10:22932119
wdt:P698
22932119
p:P1433
wds:Q56964283-C8585BA7-5506-472D-92E6-43B497BDDC5F
wdt:P1433
wd:Q6404823
p:P433
wds:Q56964283-7CC082E6-6F3A-4DCF-8729-5967BAE61DA8
p:P478
wds:Q56964283-6CB92BA3-70E9-4000-9788-87D1EF4BE7F9
wdt:P433
11
wdt:P478
82
p:P356
wds:Q56964283-5A4D5BA9-843E-466E-BB9E-E22999470EE3
wdtn:P356
n8:KI.2012.275
wdt:P356
10.1038/KI.2012.275